Saturday, June 30, 2018

Zydus Cadila gets USFDA nod for blood pressure drug

Zydus Cadila gets USFDA nod for blood pressure drug Zydus Cadila today said it has received USFDA approval to market Triamterene and Hydrochlorothiazide tablets, indicated to treat high blood pressure. The approval has been granted for the tablets in strengths of 37.5 mg/25 mg and 75 mg/50 mg.

from Moneycontrol Business News https://ift.tt/2tEouom
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Tariffs a temporary storm, structural reforms key for India: Arvind Sanger

Arvind Sanger of Geosphere Capital Management suggests a trade deal with the U.S. would benefit India by reducing market uncertainty and pro...